CapsoVision announced that it received FDA enforcement discretion to allow at-home administration of its CapsoCam Plus. Saratoga, Calif.-based CapsoVision’s CapsoCam Plus is a small bowel capsule endoscope intended for the visualization of the small bowel mucosa in adults. It does not require external equipment to be worn by the patient and it can be returned […]
NeuroMetrix launches Quell app for Apple Watch
NeuroMetrix (NSDQ:NURO) announced that it launched the Quell Watch App for transcutaneous electrical nerve stimulation (TENS). Woburn, Mass.-based NeuroMetrix’s Quell app, which is now available for download from the Apple App Store, allows users of the Quell system to personalize and manage their therapy discreetly on iPhone and Android smartphones, according to a news release. Quell […]
Medasense raises $18M Series C
Pain-response monitoring technology developer Medasense Biometrics announced today that it raised $18 million in a Series C funding round. Ramat Gan, Israel-based Medasense collected the $18 million Series C round from Sabadell Asabys venture capital firm (Asabys Partners of Spain), Israeli family offices and returning investors Baxter Ventures, Olive Tree Ventures and LGL Capital, according […]
A hospital ransomware attack may have caused a death in Germany
State authorities in North Rhine-Westphalia are investigating whether a hospital ransomware attack resulted in negligent homicide, according to a report by the German public broadcaster DW. Media reports say this may be the first time that a hospital cyberattack has caused a death, even if it was indirectly. Düsseldorf University Clinic had to redirect a […]
Abbott launches glucose biosensor for athletes in Europe
Abbott (NYSE:ABT) announced today that it is introducing the Libre Sense glucose sport biosensor for measuring athletes’ glucose. The company touts the Libre Sense as the world’s first glucose sport biosensor, using Abbott’s FreeStyle Libre continuous glucose monitor (CGM) technology to become the first personal-use product that allows for use beyond diabetes, according to a news […]
nTopology raises $40M
Engineering software developer nTopology announced that it collected $40 million in a Series C financing round. Insight Partners led the financing, with participation from Grant Verstandig and existing investors Root, Canaan, DCVC and Haystack. Josh Fredberg of Insight Partners will be joining New York-based nTopology’s board of directors as well, according to a news release. […]
Anthem, Apple to launch asthma study
Anthem (NYSE:ANTM) announced today that it is collaborating with Apple (NSDQ:AAPL) on a study using smart devices to manage asthma. Indianapolis-based Anthem and Apple are planning on examining how the use of everyday devices like the Apple Watch and iPhone can help individuals with asthma better self-manage their condition in search of improved clinical outcomes, according to […]
Livongo, Teladoc divulge more details of proposed $18.5M merger
Teladoc (NYSE:TDOC) and Livongo Health (NSDQ:LVGO) today filed a joint proxy statement in connection with a proposed merger. Last month, the companies entered into a definitive merger agreement worth approximately $18.5 million. At the time, each share of Livongo was set to be exchanged for 0.5920 shares of Teladoc, plus cash consideration of $11.33 per Livongo share, […]
NIH awards contracts to develop digital health technologies for COVID-19
The National Institutes of Health announced that it awarded seven contracts to companies to develop digital health solutions for addressing COVID-19. NIH said in a news release that the technology developed to help address the pandemic could lead to user-friendly tools like smartphone apps, wearable devices and software that can identify and trace contacts of […]
Varian wins FDA clearance for cancer therapy software
Varian Medical Systems (NYSE:VAR) announced that it received FDA 510(k) clearance for its Eclipse v16.1 treatment planning software. Palo Alto, Calif.-based Varian’s Eclipse V16.1 software is designed to enhance the visibility of soft tissue and provide more accurate information about tissue density, allowing dosimetrists to plan more precisely as they go about performing proton therapy, according […]
Medigate completes $30M Series B
Medical device security firm Medigate announced today that it completed a $30 million Series B financing round. New York-based Medigate’s funding round was led by new investor Partech, with participation from existing investors YL Ventures, U.S. Venture Partners and Blumberg Capital and new investor Maor Investments. The $30 million brings Medigate’s total funding to $50 […]
- 1
- 2
- 3
- …
- 81
- Next Page »
